Friday, 19 April 2024
2:00 to 3:30 pm CET
Increasing stakeholder engagement and empowering participants to FACILITATE the effective return of clinical trial data
Join us in the vision of this insightful overview and roundtable discussion of the FACILITATE project and its promising innovations to enable individual data return to clinical study participants.
We delved into the progress achieved to date and outline our next steps. What set this session apart is the inclusion of diverse perspectives from key stakeholders. Alongside patient testimonials, we heard from clinicians, representatives from companies, and regulatory bodies. This varied panel ensured a comprehensive discussion that reflects the project’s multidimensional impact and fosters collaboration among stakeholders.
The webinar included
- an introduction to FACILITATE and its potential innovations.
- a concise journey through achievements and future steps of the FACILITATE project.
- a Stakeholders Virtual Roundtable focused on how the project could positively impact their lives (as citizens and patients) or professional endeavors (as researchers, clinicians, pharma, etc).
Panelists
- Johanna Blom, Professor of Psychobiology Pediatric & Behavioral Neuroscience, University of Modena, and IHI FACILITATE Coordinator
- Jean Stimola-Sposaro, Director, Bristol Myers Squibb Global Industry, Human Advocate for Equity in Access, and Informed Decision Making
Roundtable
- Nuala Ryan (Moderator) Clinical Research Consultant and Patient Advocate, Takeda
- Paweł Wrona, Neurology Specialist, Investigator, Clinical Research Manager, Academic Assistant, Krakow University Hospital
- Manuel Franco-Martin, Director of the Research Group of Institute of Biomedicine of Salamanca (IBSAL), Spain
- Dorica Dan, Patients’ Representative, NoRo Center for Rare Diseases, Romania
- Nadia Malliou, Patients’ Representative, Pain Alliance Europe and Hellenic League Against Rheumatism, Greece
- Abba Elizabeth Theogaraj, TransCelerate Representative, PhD Regulatory Senior Group Director, Roche
- Andrea Manfrin, Deputy Director of Clinical Investigations, Medicines, and Healthcare Products Regulatory Agency, UK
